CA2624110A1 - Formulation de cachet - Google Patents

Formulation de cachet Download PDF

Info

Publication number
CA2624110A1
CA2624110A1 CA 2624110 CA2624110A CA2624110A1 CA 2624110 A1 CA2624110 A1 CA 2624110A1 CA 2624110 CA2624110 CA 2624110 CA 2624110 A CA2624110 A CA 2624110A CA 2624110 A1 CA2624110 A1 CA 2624110A1
Authority
CA
Canada
Prior art keywords
wafer
agent
gel
film forming
pharmaceutical agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2624110
Other languages
English (en)
Other versions
CA2624110C (fr
Inventor
Pankaj Modi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA2624110A priority Critical patent/CA2624110C/fr
Publication of CA2624110A1 publication Critical patent/CA2624110A1/fr
Application granted granted Critical
Publication of CA2624110C publication Critical patent/CA2624110C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
CA2624110A 2008-03-27 2008-03-27 Formulation en cachet a administrer oralement et a dissolution rapide Active CA2624110C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2624110A CA2624110C (fr) 2008-03-27 2008-03-27 Formulation en cachet a administrer oralement et a dissolution rapide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA2624110A CA2624110C (fr) 2008-03-27 2008-03-27 Formulation en cachet a administrer oralement et a dissolution rapide

Publications (2)

Publication Number Publication Date
CA2624110A1 true CA2624110A1 (fr) 2008-11-14
CA2624110C CA2624110C (fr) 2010-11-09

Family

ID=39971178

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2624110A Active CA2624110C (fr) 2008-03-27 2008-03-27 Formulation en cachet a administrer oralement et a dissolution rapide

Country Status (1)

Country Link
CA (1) CA2624110C (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11166912B2 (en) 2016-03-03 2021-11-09 Ctt Pharma Inc. Orally administrable composition
US11298336B2 (en) 2019-05-30 2022-04-12 Soluble Technologies, Inc. Water soluble formulation
US11786475B2 (en) 2020-07-22 2023-10-17 Soluble Technologies Inc. Film-based dosage form

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11166912B2 (en) 2016-03-03 2021-11-09 Ctt Pharma Inc. Orally administrable composition
US11298336B2 (en) 2019-05-30 2022-04-12 Soluble Technologies, Inc. Water soluble formulation
US11786475B2 (en) 2020-07-22 2023-10-17 Soluble Technologies Inc. Film-based dosage form

Also Published As

Publication number Publication date
CA2624110C (fr) 2010-11-09

Similar Documents

Publication Publication Date Title
US11337919B2 (en) Modified release drug powder composition comprising gastro-retentive RAFT forming systems having trigger pulse drug release
CN104271114B (zh) 含鸦片剂肠释放小珠的口腔膜剂
KR101367814B1 (ko) 위장체류 제제 및 이의 제조 방법
CN103889508B (zh) 用于传递丁丙诺啡的防滥用性粘膜粘附剂装置
JP5934812B2 (ja) 制御放出の製剤処方または食品処方およびその製造方法
CA3097737A1 (fr) Compositions pharmaceutiques comprenant un systeme formant un reseau polymere d'interpenetration flottant
FR2960775A1 (fr) Microgranules resistants au detournement
JPWO2006082842A1 (ja) 溶解性が改善された硬カプセル
JP2010518086A5 (fr)
WO2015164950A1 (fr) Comprimés monolithiques à base de complexes polymères de carboxyle pour la libération contrôlée de médicaments
Garg et al. Applications of natural polymers in mucoadhesive drug delivery: An overview
JP6768070B2 (ja) 粘膜付着性医薬組成物及びその製造方法
TW200900096A (en) Tablet coatings made from modified carboxymethylcellulose materials
CA2624110A1 (fr) Formulation de cachet
WO2012070785A1 (fr) Composition pharmaceutique à libération contrôlée comprenant du lévétiracétam ou un sel pharmaceutiquement acceptable de celui-ci présentant une stabilité de dissolution améliorée et procédé pour sa fabrication
AU2012390362B2 (en) Oral preparation and method for producing the same
TR202016210A2 (tr) Asidik madde içeren farmasötik form
CN105012276A (zh) 一种咪达那新口腔速溶膜及其制备方法和用途
CN104940173A (zh) 可溶性芬太尼及其衍生物口颊膜制剂及其制备方法
Shivashankar et al. Formulation and evaluation of bupivacaine-loaded glutaraldehyde-crosslinked high molecular weight chitosan microspheres
DE102010049706A1 (de) Herstellung orodispersibler Filme
RU2411035C2 (ru) Лекарственная форма с модифицированным высвобождением 6-метил-2-этил-3-гидроксипиридина сукцината
CN104146979A (zh) 盐酸普拉克索缓释片及制备方法
Mishra et al. Development and in vitro evaluation of hydrophilic matrix tablets of diltiazem hydrochloride
AU2018388577B2 (en) Modified release drug powder composition comprising gastro-retentive raft forming systems having trigger pulse drug release

Legal Events

Date Code Title Description
EEER Examination request